Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 1,773.00
-24.00 (-1.34%)
Apr 29, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 30.66 billion as of April 29, 2026. Its market cap has decreased by -18.98% in one year.
Market Cap
30.66B
Enterprise Value
29.24B
Revenue
1.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,773.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 30.66B, a decrease of -66.01%. That is a compound annual growth rate of -45.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 30.66B | 6.74% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIENT BIO | 66.04B |
| GeneOne Life Science | 91.67B |
| CG Invites | 98.96B |
| IMB Dx | 102.61B |
| Oncocross | 107.32B |
| iNtRON Biotechnology | 120.13B |
| Amicogen | 131.18B |
| ENCell | 176.61B |